NCT06370533

Brief Summary

This study aims to evaluate the efficacy of a multi-component lifestyle interventions during pregnancy on promoting appropriate gestational weight gain, preventing GDM, and improving pregnancy, delivery, and neonatal outcomes among overweight or obese pregnant women. The intervention strategies are developed based on the transtheoretical model and mobile health (via WeChat Public Account in smartphone), and will be conducted online and offline. This study will recruit and follow-up 200 overweight or obese singleton pregnant women (pre-pregnancy 24kg/m2≤BMI≤40 kg/m2) during the first trimester of pregnancy from Weifang Maternal and Child Health Hospital, Shandong Province, China, and Tongzhou Maternal and Child Health-care Institution, Beijing, China, with 100 pregnancy women in each institution. The 200 overweight or obese pregnant women will be randomly allocated at a 1:1 ratio to either the intervention or control group, stratified by the categorical variables of age, BMI and parity. Participants in the control group will be provided usual prenatal care. The lifestyle intervention will last for approximately 6 months (from 10-14 weeks to 32-36 weeks of gestation). Follow-up timepoints included 8-14 weeks of gestation, 24-28 weeks of gestation, 32-36 weeks of gestation. The interventions are composed of health education related to gestational weight gain and healthy lifestyles, diet modification, active physical activity, regular individual in-person and telephone sessions, diet behavior monitoring, physical activity monitoring, and weight monitoring with Huawei Wristband and WeChat Public Account. The hypothesis is that lifestyle interventions based on the transtheoretical model and mobile health will result in more appropriate gestational weight gain and lower risk of adverse pregnancy outcomes compared with usual care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2024

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 31, 2024

Completed
17 days until next milestone

First Posted

Study publicly available on registry

April 17, 2024

Completed
2 days until next milestone

Study Start

First participant enrolled

April 19, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2026

Completed
Last Updated

April 13, 2026

Status Verified

March 1, 2026

Enrollment Period

12 months

First QC Date

March 31, 2024

Last Update Submit

April 8, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Total gestational weight gain

    Weight at gestational week 32-36 minus pre-pregnancy weight (kilograms)

    From pre-pregnancy to gestational week 32-36

  • Gestational weight gain before OGTT screening

    Gestational weight gain before OGTT screening at 24-28 weeks (kilograms)

    From pre-pregnancy to midterm (24-28 weeks)

Secondary Outcomes (8)

  • Weekly rate of gestational weight gain between study clinical assessments

    Gestational weight gain from pre-pregnancy/baseline (8-14 weeks) to midterm (24-28 weeks)/terminal (32-36 weeks)

  • Proportion of women who exceed the IOM guidelines' weekly rate of gestational weight gain between clinical assessments

    From pre-pregnancy/baseline (8-14 weeks) to midterm (24-28 weeks)/terminal (32-36 weeks)

  • Rate of Gestational Diabetes Mellitus diagnosed according to International Association of Diabetes and Pregnancy Study Group (IADPSG) criteria

    OGTT screening at 24-28 gestational weeks

  • Rate of Preeclampsia/Gestational hypertension

    From 20 weeks of gestation to delivery

  • Rate of Cesarean Section

    At delivery

  • +3 more secondary outcomes

Other Outcomes (17)

  • Change of Blood pressure

    From baseline (8-14 weeks) to midterm (24-28 weeks)/terminal (32-36 weeks)

  • Change of body fat percentage (%)

    From baseline (8-14 weeks) to midterm (24-28 weeks)/terminal (32-36 weeks)

  • Change of fat free mass (kg)

    From baseline (8-14 weeks) to midterm (24-28 weeks)/terminal (32-36 weeks)

  • +14 more other outcomes

Study Arms (2)

lifestyle intervention

EXPERIMENTAL

Health education: Individual face to face or telephone sessions and online health education material. Diet behavior: The eight eating behavioral goals will be assigned to each participant with two for every 4-week cycle. Physical activity: Women will be advised to gradually attaining the goal of 150 minutes of moderate- to vigorous-intensity physical activity per week and walk at least 6000 steps per day. Weight monitoring: Self-monitoring of weight gain (regular self-weighing) and weight logging at least once a week was recommended.

Behavioral: behavioral interventions

usual-care control

NO INTERVENTION

Provision of usual prenatal care

Interventions

The investigators set diet, physical activity, and weight goals for each participant. During the lifestyle intervention period, the participants need to complete weekly self-monitoring of weight, weekly recording of diet behavioral goals, timely exercise logging, online health education course learning by using the WeChat public account. They will receive corresponding timely reminder and tailored feedback in the form of graphical illustration and text according to diet, physical activity, and weight data collected by WeChat public account and Huawei Wristband. They will receive individual face to face or telephone sessions every 2 weeks to complete health education, goal review, motivational interview as well as collecting adverse events.

lifestyle intervention

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • At 8-14 weeks of gestation
  • Overweight or obese (pre-pregnancy 40 kg/m2≥BMI≥24 kg/m2) based on BMI recommendations of the Group of China Obesity Task Force of the Chinese Ministry of Health accounting for interracial differences (overweight BMI 24-28 kg/m2 and obese BMI≥28kg/m2)
  • years of age
  • Singleton pregnant
  • Skilled at using smartphones and WeChat during pregnancy
  • Attend regular antenatal care and plan delivery at W.F. Maternal and Child Health Hospital or Tongzhou Maternal and Child Health-care Institution of Beijing
  • No contraindications to physical activity according to Physical Activity Readiness Questionnaire (PAR-Q)
  • Willing to be randomized and cooperate with research and regular follow-up visits and sign informed consent.

You may not qualify if:

  • Pre-pregnancy hypertension, severe cardiovascular and cerebrovascular diseases, respiratory disease, hepatic and renal disease, malignant tumors, systemic lupus erythematosus, thyroid disease, severe anemia, and other chronic consumptive diseases.
  • Cervical insufficiency (historical painless cervical dilation leading to recurrent second-trimester births in the absence of other causes; dilated cervix on manual or speculum examination, etc.), multiple pregnancy, or continuous vaginal bleeding, etc.
  • Diabetes before pregnancy
  • Special dietary needs (e.g. , vegetarianism)
  • Severe psychiatric disorders (serious mental health disorders including depression, anxiety, bipolar disorders, etc.)
  • Cognitive impairment, visual impairment or hearing impairment
  • History of bariatric surgery or surgical history involving important organs within 3 months
  • Participated in other clinical trials within 6 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Tongzhou Maternal and Child Health-care Institution

Beijing, Beijing Municipality, China

Location

W.F. Maternal and Child Health Hospital;

Weifang, Shandong, China

Location

MeSH Terms

Conditions

Gestational Weight GainOverweightObesity

Interventions

Behavior Therapy

Condition Hierarchy (Ancestors)

Weight GainBody Weight ChangesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsOvernutritionNutrition DisordersNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

PsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Haixue Wang, Doctor

    Peking University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 31, 2024

First Posted

April 17, 2024

Study Start

April 19, 2024

Primary Completion

March 31, 2025

Study Completion

March 31, 2026

Last Updated

April 13, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations